CAS: 1883423-59-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MSC2530818 REF: IN-DA01EOQ5CAS: 1883423-59-3 | % | 54.00 €~503.00 € | Wed 04 Dec 24 |
 | MSC2530818 REF: TM-TQ0266CAS: 1883423-59-3 | 99.33% | 65.00 €~1,003.00 € | Wed 11 Dec 24 |
 | MSC2530818 REF: 3D-IAD42359CAS: 1883423-59-3 | Min. 95% | To inquire | Wed 15 Jan 25 |
Ref: IN-DA01EOQ5
| 5mg | 54.00 € | ||
| 10mg | 69.00 € | ||
| 25mg | 110.00 € | ||
| 50mg | 186.00 € | ||
| 100mg | 224.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
MSC2530818
CAS:1883423-59-3
MSC2530818 is an effective, selective and orally available CDK8 inhibitor (IC50: 2.6 nM).
Formula:
C18H17ClN4O
Purity:
99.33%
Color and Shape:
Solid
Molecular weight:
340.81
Ref: TM-TQ0266
| 1mg | 65.00 € | ||
| 5mg | 143.00 € | ||
| 10mg | 227.00 € | ||
| 25mg | 497.00 € | ||
| 50mg | 723.00 € | ||
| 100mg | 1,003.00 € | ||
| 1mL*10mM (DMSO) | 159.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
MSC2530818
CAS:1883423-59-3
MSC2530818 is a small molecule kinase inhibitor that is selective for the epidermal growth factor …
Formula:
C18H17ClN4O
Purity:
Min. 95%
Molecular weight:
340.81 g/mol
Ref: 3D-IAD42359
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
